Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Nutex Health (NUTX) Leases (2019 - 2026)

Nutex Health (NUTX) has disclosed Leases for 8 consecutive years, with $220.7 million as the latest value for Q1 2026.

  • For Q1 2026, Leases rose 2.08% year-over-year to $220.7 million; the TTM value through Mar 2026 reached $220.7 million, up 2.08%, while the annual FY2025 figure was $222.4 million, 1.59% up from the prior year.
  • Leases hit $220.7 million in Q1 2026 for Nutex Health, down from $222.4 million in the prior quarter.
  • Across five years, Leases topped out at $225.7 million in Q3 2025 and bottomed at $86989.0 in Q1 2022.
  • Average Leases over 5 years is $159.4 million, with a median of $194.8 million recorded in 2022.
  • On a YoY basis, Leases climbed as much as 239722.81% in 2023 and fell as far as 91.42% in 2023.
  • Nutex Health's Leases stood at $192.6 million in 2022, then decreased by 8.54% to $176.1 million in 2023, then increased by 24.27% to $218.9 million in 2024, then grew by 1.59% to $222.4 million in 2025, then dropped by 0.75% to $220.7 million in 2026.
  • According to Business Quant data, Leases over the past three periods came in at $220.7 million, $222.4 million, and $225.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.